Hectort, you are missing the point and misleading the people. It is the well-recognised fact that Patrys is a company that owns superior patented technologies and has got orphan status of its two products. The company are now focused on product commercialisation which should be No. 1 priority at this stage. In biotech industry, one successfully commercialised product can make a company!
It is a common sense that, without inbound cash flow and cash positive, a company will definitely go out of business even if it has a strong R&D team.
Hectort, you are missing the point and misleading the people. It...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5382389 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2352699 | 1 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable